The likelihood that a person with early-stage non-small cell lung cancer will receive curative treatment still varies considerably by race, even though 3 decades have passed since researchers first ...
A rapidly growing patient population has Sarasota Memorial Hospital issuing an urgent call for experienced local registered nurses (RNs) to join its expanding Oncology ...
As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...